{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:48:30Z","timestamp":1791215310546,"version":"4.1.0"},"reference-count":37,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2013,4,7]],"date-time":"2013-04-07T00:00:00Z","timestamp":1365292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The aim of the study was to investigate the incidence of <jats:styled-content style=\"fixed-case\">AIDS<\/jats:styled-content>\u2010defining cancers (<jats:styled-content style=\"fixed-case\">ADCs<\/jats:styled-content>) and virus\u2010related and non\u2010virus\u2010related non\u2010<jats:styled-content style=\"fixed-case\">AIDS<\/jats:styled-content>\u2010defining cancers (<jats:styled-content style=\"fixed-case\">NADCs<\/jats:styled-content>) in <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010infected patients compared with the general population, and to assess the risk factors associated with these malignancies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a retrospective cohort study for the period from 1999 to 2009 of <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010infected patients residing in the <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>ocal <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>ealth <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>uthority of <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>rescia (northern <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>taly). Observed cancers in patients with <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> infection were compared with expected cancers in the population living in the same area using standardized incidence ratios (<jats:styled-content style=\"fixed-case\">SIRs<\/jats:styled-content>). Risk factors were assessed using <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>oisson regression analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 5090 <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010infected patients were included in the study, with 32\u2009390 person\u2010years of follow\u2010up. We recorded 416 tumours in 390 <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010infected patients. Two hundred of these (48.1%) were <jats:styled-content style=\"fixed-case\">ADCs<\/jats:styled-content>, 138 (33.2%) were non\u2010virus\u2010related <jats:styled-content style=\"fixed-case\">NADCs<\/jats:styled-content> and 78 (18.7%) were virus\u2010related <jats:styled-content style=\"fixed-case\">NADCs<\/jats:styled-content>. An increased risk (<jats:styled-content style=\"fixed-case\">SIR<\/jats:styled-content>\u2009=\u20094.2) of cancers overall was found in <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010infected patients. A large excess of <jats:styled-content style=\"fixed-case\">ADCs<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">SIR<\/jats:styled-content>\u2009=\u200931.0) and virus\u2010related <jats:styled-content style=\"fixed-case\">NADCs<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">SIR<\/jats:styled-content>\u2009=\u200912.3) was observed in <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010infected patients, while the excess risk for non\u2010virus\u2010related <jats:styled-content style=\"fixed-case\">NADCs<\/jats:styled-content> was small (<jats:styled-content style=\"fixed-case\">SIR<\/jats:styled-content>\u2009=\u20091.6). The highest <jats:styled-content style=\"fixed-case\">SIRs<\/jats:styled-content> were observed for Kaposi sarcoma among <jats:styled-content style=\"fixed-case\">ADCs<\/jats:styled-content> and for Hodgkin lymphoma among virus\u2010related <jats:styled-content style=\"fixed-case\">NADCs<\/jats:styled-content>. Conversely, among non\u2010virus\u2010related <jats:styled-content style=\"fixed-case\">NADCs<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">SIRs<\/jats:styled-content> for a broad range of malignancies were close to unity. In multivariate analysis, increasing age and <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4 cell count &lt;\u200950\u2009cells\/\u03bcL were the only factors independently associated with all cancers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Among <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010infected people there was an excess of <jats:styled-content style=\"fixed-case\">ADCs<\/jats:styled-content> and also of <jats:styled-content style=\"fixed-case\">NADCs<\/jats:styled-content>, particularly those related to viral infections. Ageing and severe immunodeficiency were the strongest predictors.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.12034","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T01:48:40Z","timestamp":1365385720000},"page":"481-490","source":"Crossref","is-referenced-by-count":75,"title":["Incidence of <scp>AIDS<\/scp>\u2010defining cancers and virus\u2010related and non\u2010virus\u2010related non\u2010<scp>AIDS<\/scp>\u2010defining cancers among <scp>HIV<\/scp>\u2010infected patients compared with the general population in a large health district of northern <scp>I<\/scp>taly, 1999\u20132009"],"prefix":"10.1111","volume":"14","author":[{"given":"A","family":"Calabresi","sequence":"first","affiliation":[{"name":"University Division of Infectious and Tropical Diseases University of Brescia, Brescia Spedali Civili General Hospital  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ferraresi","sequence":"additional","affiliation":[{"name":"University Division of Infectious and Tropical Diseases University of Brescia, Brescia Spedali Civili General Hospital  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Festa","sequence":"additional","affiliation":[{"name":"Institute of Hygiene, Epidemiology and Public Health University of Brescia  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Scarcella","sequence":"additional","affiliation":[{"name":"Local Health Authority of the Brescia Province  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Donato","sequence":"additional","affiliation":[{"name":"Institute of Hygiene, Epidemiology and Public Health University of Brescia  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Vassallo","sequence":"additional","affiliation":[{"name":"Local Health Authority of the Brescia Province  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RM","family":"Limina","sequence":"additional","affiliation":[{"name":"Institute of Hygiene, Epidemiology and Public Health University of Brescia  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Castelli","sequence":"additional","affiliation":[{"name":"University Division of Infectious and Tropical Diseases University of Brescia, Brescia Spedali Civili General Hospital  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Quiros\u2010Roldan","sequence":"additional","affiliation":[{"name":"University Division of Infectious and Tropical Diseases University of Brescia, Brescia Spedali Civili General Hospital  Brescia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Brescia HIV Cancer Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,4,7]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji072"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000238411.75324.59"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.096"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.8252"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-10-200805200-00005"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23487"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32802ef30c"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1086\/596766"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832e9b78"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200408010-00013"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1528"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2004.09.011"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206637"},{"key":"e_1_2_5_15_1","unstructured":"International Agency for Research on Cancer (IARC) Working group on the Evaluation of Carcinogenic Risks to Humans.IARC Monographs on the evaluation of carcinogenic risks to humans.1997; volume70: Epstein\u2010Barr Virus and Kaposi's sarcoma Herpes virus\/HumanHerpesvirus."},{"key":"e_1_2_5_16_1","unstructured":"International Agency for Research on Cancer (IARC) Working group on the Evaluation of Carcinogenic Risks to Humans.IARC Monographs on the evaluation of carcinogenic risks to humans.1994; volume59: Hepatitis viruses."},{"key":"e_1_2_5_17_1","unstructured":"International Agency for Research on Cancer (IARC) Working group on the Evaluation of Carcinogenic Risks to Humans.IARC Monographs on the evaluation of carcinogenic risks to humans.2005; volume90: HumanPapillomaviruses."},{"key":"e_1_2_5_18_1","article-title":"A population\u2010based database to study malignancies in HIV\u2010infected patients in the Local Agency of Brescia between 1999 and 2009","author":"Calabresi A","year":"2011","journal-title":"Epidemiol Prev"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.1713"},{"key":"e_1_2_5_20_1","unstructured":"BreslowNE DayNE.Statistical methods in cancer research. The design and analysis of cohort studies. International Agency for Research of Cancer (IARC) scientific publication1987; No 82 volII."},{"key":"e_1_2_5_21_1","unstructured":"Regione Lombardia\/ASL Brescia.Documento di programmazione e coordinamento dei servizi sanitari e socio\u2010sanitari dell'ASL di Brescia per l'anno2012. Available atwww.aslbrescia.it\/media\/pdf\/2012%20Documento%20di%20programmazione.pdf(accessed 25 September 2012)."},{"key":"e_1_2_5_22_1","first-page":"1","article-title":"Aggiornamento delle nuove diagnosi di infezione da HIV al 31 dicembre 2009 e dei casi di AIDS in Italia al 31 dicembre 2010","volume":"24","author":"Centro Operativo AIDS","year":"2011","journal-title":"Supplemento del notiziario dell'Istituto Superiore di Sanit\u00e0"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25153"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604923"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1086\/651688"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/2047-783X-16-3-101"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir207"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25311"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605756"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyh307"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01169-5"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1086\/343862"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e328329c5b2"},{"key":"e_1_2_5_34_1","first-page":"70","article-title":"AIDS\u2010related malignancies: revisited","volume":"29","author":"C\u00e1ceres W","year":"2010","journal-title":"P R Health Sci J"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835935b3"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70282-7"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328317cc2d"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.6626"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhiv.12034","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.12034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T06:43:50Z","timestamp":1696315430000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.12034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,7]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1111\/hiv.12034"],"URL":"https:\/\/doi.org\/10.1111\/hiv.12034","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,7]]}}}